Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-10-15

Clinical Trial Update: Clinical Study of Probiotic Treatment for Androgenetic Alopecia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a probiotic treatment for androgenetic alopecia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic treatment for androgenetic alopecia (study product) (probiotic therapy)

Snippet

Sponsor: Applied Biology, Inc. | Conditions: Androgenetic Alopecia, Female Pattern Baldness | Phase 3 | Status: WITHDRAWN